Fig. 5From: Optimization and scale up of microfluidic nanolipomer production method for preclinical and potential clinical trialsIn vitro functional assessment of nanolipomers. a–c. C4-2B prostate cancer cell uptake experiment at 1 and 24 h. d Cell viability of C4-2B cells after 48 h of treatment. e Cell viability of C4-2B cells after 72 h of treatment (n = 3: mean ± SD)Back to article page